← Open Payments lookup

DAVID HAUSER: Open Payments

NPI 1992006852 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,621 in 91 payments from 16 companies in 2025. Trend: 2023 $225 · 2024 $1,026 · 2025 $1,621

Food & beverage: $1,622
CompanyPaymentsAmount
ABBVIE INC.27$334
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$238
Vanda Pharmaceuticals Inc.11$226
Corium, LLC10$222
Lundbeck LLC9$165
Axsome Therapeutics, Inc.4$89
Otsuka America Pharmaceutical, Inc.3$65
Biogen, Inc.3$55
Takeda Pharmaceuticals U.S.A., Inc.3$53
Neurocrine BioSciences, Inc.2$41

Products named: VRAYLAR, CAPLYTA, REXULTI, FANAPT, Azstarys, Auvelity, ZURZUVAE, TRINTELLIX.

Industry payments across AZ — which companies pay providers there.